BioChange Overview
BioChange specializes in tissue regeneration technology and is the developer of CellFoam, an injectable scaffold that stimulates tissue repair and remodeling at the site of injection. Based on natural biomaterials designed for implantation using a minimally invasive procedure, the scaffold mimics the healthy extra-cellular matrix and triggers the body to repair itself.
Cumulative Funding Raised Over Time ($)
Latest News
Israeli foam to reverse receding gums soon set for human use, after success on dogs
growth-positive
Dental implant holds promise for gum repair, regeneration - ISRAEL21c
Israeli startup BioChange has developed a tissue regeneration technology, ReGum, that has been shown to be effective in healing gum disease in dogs. The product is now commercially available for veterinary use and is reportedly the only product of its kind. A formulation for humans is expected within a few years. The products success was reported in the journal Frontiers in Veterinary Science. The company is now selling products in the veterinary and research markets and is committed to beginning its first clinical study in aesthetic dermatology in 2023.
CustomersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $3.05M |
| Last funding | $3M |
| Stage | Seed |
| Rounds | 3 |
| Investors | 2 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | biochange.life/?v=4605f628f91d |
Locations
HaYetsira St 13, Yokne'am Illit, Israel
Photos & Videos
2 item(s)
